August 24, 2026

The German conglomerate is focused on containing litigation uncertainty, reducing debt and internal bureaucracy, strengthening the drug pipeline of its pharma business, and improving the profitability of its agriculture unit.

Leave a Reply

Your email address will not be published. Required fields are marked *